Synthesis of different types of dipeptide building units containing N- or C-terminal arginine for the assembly of backbone cyclic peptides.
暂无分享,去创建一个
[1] G. Bitan,et al. Synthesis and biological activity of novel backbone-bicyclic substance-P analogs containing lactam and disulfide bridges. , 2009, The journal of peptide research : official journal of the American Peptide Society.
[2] D. Scherman,et al. Synthesis of novel (N-farnesyl) amino acids and their incorporation into peptides. , 2009, International journal of peptide and protein research.
[3] K. Kaljuste,et al. A new general solid-phase method for the synthesis of backbone-to-backbone cyclized peptides. , 2009, International journal of peptide and protein research.
[4] V. Antonenko,et al. Comparative study of methods to couple hindered peptides. , 2009, International journal of peptide and protein research.
[5] B. Müller,et al. Synthesis of differentially protected N‐acylated reduced pseudodipeptides as building units for backbone cyclic peptides , 2000, Journal of Peptide Science.
[6] S. Reissmann,et al. Synthesis of N-carboxyalkyl and N-aminoalkyl functionalized dipeptide building units for the assembly of backbone cyclic peptides. , 1999, The journal of peptide research : official journal of the American Peptide Society.
[7] C. Gilon,et al. In situ generation of Fmoc-amino acid chlorides using bis-(trichloromethyl) carbonate and its utilization for difficult couplings in solid-phase peptide synthesis. , 1999, The journal of peptide research : official journal of the American Peptide Society.
[8] M. Filizola,et al. Conformational analysis of the highly potent bradykinin antagonist Hoe-140 by means of two different computational methods. , 1998, Journal of biomolecular structure & dynamics.
[9] J. Stewart,et al. A comparative NMR and molecular dynamics study of the conformations of bradykinin B1 and B2, B2, and B1‐specific receptor antagonists B‐9430, B‐9436, and B‐9858 , 1997, Biopolymers.
[10] G. Bitan,et al. Building Units for N-Backbone Cyclic Peptides. 3. Synthesis of Protected Nα-(ω-Aminoalkyl)amino Acids and Nα-(ω-Carboxyalkyl)amino Acids , 1997 .
[11] G. Bitan,et al. Synthesis and biological activity of NK-1 selective, N-backbone cyclic analogs of the C-terminal hexapeptide of substance P. , 1996, Journal of medicinal chemistry.
[12] H. Wenschuh,et al. Peptide Synthesis via Amino Acid Halides , 1996 .
[13] S. Reissmann,et al. A new type of bradykinin B2 receptor antagonists: bradykinin analogs with N-alkyl amino acids at position 2. , 1996, Immunopharmacology.
[14] J. Stewart,et al. An NMR, CD, molecular dynamics, and fluorometric study of the conformation of the bradykinin antagonist B-9340 in water and in aqueous micellar solutions. , 1995, Journal of medicinal chemistry.
[15] C. Gilon,et al. Building units for N-Backbone cyclic peptides. 2. Synthesis of protected N-(ω-thioalkylene) amino acids and their incorporation into dipeptide units , 1995 .
[16] W. Guba,et al. Combined Approach of NMR and Molecular Dynamics within a biphasic Membrane Mimetic: Conformation and Orientation of the Bradykinin Antagonist Hoe 140 , 1994 .
[17] H. Kessler,et al. Conformational Analysis of a Cyclic RGD Peptide Containing a .psi.[CH2-NH] Bond: A Positional Shift in Backbone Structure Caused by a Single Dipeptide Mimetic , 1994 .
[18] J. Stewart,et al. A proton magnetic resonance study of two synthetic agonist–antagonist pairs of bradykinin analogues , 1993, Biopolymers.
[19] G. Byk,et al. Building units for N-backbone cyclic peptides. 1. Synthesis of protected N-(.omega.-aminoalkylene)amino acids and their incorporation into dipeptide units , 1992 .
[20] Roger M. Freidinger,et al. Use of N-Fmoc amino acid chlorides and activated 2-(fluorenylmethoxy)-5(4H)-oxazolones in solid-phase peptide synthesis. Efficient syntheses of highly N-alkylated cyclic hexapeptide oxytocin antagonists related to L-365,209 , 1992 .
[21] G. Byk,et al. Backbone cyclization: A new method for conferring conformational constraint on peptides , 1991, Biopolymers.
[22] N. Rhaleb,et al. [Phe8 psi(CH2-NH)Arg9]bradykinin, a B2 receptor selective agonist which is not broken down by either kininase I or kininase II. , 1988, European journal of pharmacology.
[23] D. Coy,et al. Solid phase synthesis of peptides containing the CH2NH peptide bond isostere , 1987, Peptides.
[24] J. Fehrentz,et al. An Efficient Synthesis of Optically Active α-(t-Butoxycarbonylamino)-aldehydes from α-Amino Acids , 1983 .
[25] J. R. Vaughan. ACYLALKYLCARBONATES AS ACYLATING AGENTS FOR THE SYNTHESIS OF PEPTIDES , 1951 .
[26] G. Bitan,et al. Building units for N-backbone cyclic peptides. Part 4.1Synthesis of protected Nα-functionalized alkyl aminoacids by reductive alkylation of natural amino acids , 1997 .
[27] A. Gołębiowski,et al. Optically active N-protected .alpha.-amino aldehydes in organic synthesis , 1989 .
[28] D. Coy,et al. Solid phase reductive alkylation techniques in analogue peptide bond and sidechain modification , 1988 .